Introduction Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is an advanced oncologic perfusion technique designed to treat peritoneal carcinomatosis, a condition where cancer spreads within the peritoneal cavity (Sugarbaker, 1995). This innovative approach..
Read More
Usage of HIPEC techniques for the first time in thoracic organs in advanced CA of pericardium. Dr.Sam Zeraatian Nejad Davani, CEO of rockingham medical research ADKWA center as well..
Read More
Abstract Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have demonstrated their impact on disease-free survival (DFS) and overall survival (OS) of patients with peritoneal metastases (PM). However, prior literature..
Read More
Abstract Importance Peritoneal metastasis in patients with locally advanced colon cancer (T4 stage) is estimated to recur at a rate of approximately 25% at 3 years from surgical resection and is..
Read More
Abstract Hyperthermic intraperitoneal chemotherapy (HIPEC) has been shown to be an effective treatment for peritoneal tumors; whether preventive HIPEC after radical resection for T4 stage colon adenocarcinoma could decrease peritoneal..
Read More
Abstract Advanced epithelial ovarian cancer (EOC) has a well-characterized pattern of spread; the cancer cells tend to stay within the peritoneal cavity, attaching to organ surfaces and only invading superficial..
Read More
Abstract Importance Studies on the prognostic role of hyperthermic intraperitoneal chemotherapy (HIPEC) in pseudomyxoma peritonei (PMP) are currently not available. Objectives To evaluate outcomes after cytoreductive surgery (CRS) and HIPEC compared with..
Read More
Abstract Background and (CRS-HIPEC) is now the preferred treatment of many peritoneal surface malignancies. In this retrospective study we aimed to analyze how several performance indicators changed during the first 100..
Read More